History
  • No items yet
midpage
Harrington v. Purdue Pharma L.P.
603 U.S. 204
SCOTUS
2024
Read the full case

Background

  • Purdue Pharma, controlled by the Sackler family, marketed OxyContin and faced extensive opioid-related litigation; Purdue filed Chapter 11 in 2019.
  • Sackler family members had extracted roughly $11 billion from Purdue; in the Chapter 11 negotiations they agreed to contribute roughly $4.3 billion (later increased) in exchange for releases and an injunction freeing them from present and future opioid claims.
  • Purdue’s Chapter 11 plan included a broad nonconsensual third‑party release and injunction (the "Sackler discharge") extinguishing claims against Sackler family members without victims’ consent.
  • The bankruptcy court confirmed the plan; the district court vacated confirmation holding the Code does not authorize nonconsensual third‑party discharges; a divided Second Circuit reversed and reinstated confirmation.
  • The Supreme Court granted certiorari to resolve the circuit split and held that the Bankruptcy Code does not authorize a plan provision that effectively discharges claims against a nondebtor without the consent of affected claimants.

Issues

Issue Plaintiff's Argument (U.S. Trustee) Defendant's Argument (Purdue / Sacklers) Held
Whether §1123(b)(6) permits a nonconsensual release/discharge of claims against nondebtors §1123(b)(6) cannot be read to grant courts power to extinguish nondebtor claims without consent; catchall must be read in context §1123(b)(6) is a broad residual grant allowing "any other appropriate" provisions not forbidden by the Code, so nonconsensual releases are permitted The catchall must be read by ejusdem generis and in context; it does not authorize nonconsensual third‑party discharges of nondebtors without claimants' consent; reversed Second Circuit
Whether §105(a) independently authorizes nonconsensual third‑party releases §105(a) only carries out provisions elsewhere in the Code and cannot create freestanding authority to discharge nondebtors §105(a) empowers bankruptcy courts to issue orders necessary or appropriate to carry out the Code, which can include such releases §105(a) cannot supply independent authority to impose nonconsensual releases that the Code does not otherwise permit
Whether a plan that effectively gives nondebtors discharge would circumvent Code limits on discharge and asset‑surrender requirements Nondebtor releases would let nonfiling parties avoid Code limits (e.g., requirement to place substantially all assets in estate; exceptions for fraud/willful injury) Characterizing the relief as a "release," not a bankruptcy discharge, circumvents discharge limitations and is permissible Allowing the Sackler-style release would evade statutory constraints (asset surrender and exceptions to discharge); Code structure forecloses that result
Role of history, precedent, and policy (collective‑action problem / mass‑tort settlements) Historical practice and statutory structure do not support extending debtor discharges to nondebtors; policy choices belong to Congress Longstanding bankruptcy practice and equitable policy support narrow, case‑specific nondebtor releases to solve mass‑tort collective‑action problems History and Code text favor limiting extraordinary nonconsensual releases to contexts where Congress provided them (e.g., §524(g)); policy arguments cannot override statutory text

Key Cases Cited

  • Epic Systems Corp. v. Lewis, 584 U.S. 497 (2018) (canon of interpreting catchall terms in context and ejusdem generis)
  • RadLAX Gateway Hotel, LLC v. Amalgamated Bank, 566 U.S. 639 (2012) (pre‑Code practice may inform ambiguous provisions)
  • Dewsnup v. Timm, 502 U.S. 410 (1992) (interpretive caution—Congress would speak expressly for major departures)
  • United States v. Energy Resources Co., 495 U.S. 545 (1990) (§1123(b)(6) can support plan provisions serving reorganization success)
  • Tennessee Student Assistance Corp. v. Hood, 541 U.S. 440 (2004) (effect of discharge and injunctive operation under the Code)
  • In re Johns‑Manville Corp., 837 F.2d 89 (2d Cir. 1988) (example of historical mass‑tort plan approving nondebtor releases relied upon by dissent)
Read the full case

Case Details

Case Name: Harrington v. Purdue Pharma L.P.
Court Name: Supreme Court of the United States
Date Published: Jun 27, 2024
Citation: 603 U.S. 204
Docket Number: 23-124
Court Abbreviation: SCOTUS